Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UHT
2326
Universal Health Realty Income Trust
UHT
$573M
| $5.57M | ﹤0.01% |
100,683
+504
| +0.5% | +$29.7K |
|
2327
American Public Education
APEI
$826M
| $5.56M | ﹤0.01% |
217,057
+13,189
| +6% | +$361K |
|
|
DSEY
2328
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
| $5.52M | ﹤0.01% |
344,105
+24,895
| +8% | +$412K |
|
2329
Tencent Music
TME
$14.2B
| $5.51M | ﹤0.01% |
760,331
+10,186
| +1% | +$99.8K |
|
|
GSKY
2330
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $5.49M | ﹤0.01% |
491,376
+93,006
| +23% | +$731K |
|
|
FBMS
2331
DELISTED
The First Bancshares, Inc.
FBMS
| $5.49M | ﹤0.01% |
141,619
-784
| -0.6% | -$30.3K |
|
2332
Protagonist Therapeutics
PTGX
$9.8B
| $5.49M | ﹤0.01% |
309,832
+28,454
| +10% | +$1.21M |
|
2333
Costamare
CMRE
$1.71B
| $5.49M | ﹤0.01% |
354,256
-42,998
| -11% | -$554K |
|
|
RIDE
2334
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
| $5.48M | ﹤0.01% |
45,751
-3,704
| -7% | -$385K |
|
2335
Peoples Bancorp
PEBO
$1.48B
| $5.41M | ﹤0.01% |
170,966
+46,399
| +37% | +$1.4M |
|
2336
Olema Pharmaceuticals
OLMA
$913M
| $5.4M | ﹤0.01% |
196,024
+114,590
| +141% | +$3.09M |
|
|
CIO
2337
DELISTED
City Office REIT
CIO
| $5.38M | ﹤0.01% |
301,310
+5,258
| +2% | +$76.5K |
|
|
GOOD
2338
Gladstone Commercial Corp
GOOD
$630M
| $5.38M | ﹤0.01% |
255,754
+4,555
| +2% | +$102K |
|
|
NFBK
2339
DELISTED
Northfield Bancorp
NFBK
| $5.38M | ﹤0.01% |
313,204
-5,410
| -2% | -$89.1K |
|
2340
QCR Holdings
QCRH
$1.73B
| $5.35M | ﹤0.01% |
104,080
-21,532
| -17% | -$1.06M |
|
2341
Sportsman's Warehouse
SPWH
$46M
| $5.35M | ﹤0.01% |
304,181
+3,375
| +1% | +$59.8K |
|
|
RUBY
2342
DELISTED
Rubius Therapeutics, Inc
RUBY
| $5.35M | ﹤0.01% |
299,122
-6,925
| -2% | -$151K |
|
2343
Teva Pharmaceuticals
TEVA
$42.6B
| $5.34M | ﹤0.01% |
547,898
+17,101
| +3% | +$160K |
|
|
PLYA
2344
DELISTED
Playa Hotels & Resorts
PLYA
| $5.33M | ﹤0.01% |
642,754
+187,852
| +41% | +$1.33M |
|
2345
Johnson Outdoors
JOUT
$499M
| $5.3M | ﹤0.01% |
50,078
-141
| -0.3% | -$16.1K |
|
2346
IDT Corp
IDT
$1.63B
| $5.3M | ﹤0.01% |
126,267
+77,525
| +159% | +$3.62M |
|
|
SRDX
2347
DELISTED
Surmodics
SRDX
| $5.29M | ﹤0.01% |
95,218
+573
| +0.6% | +$31.8K |
|
|
CCF
2348
DELISTED
Chase Corporation
CCF
| $5.29M | ﹤0.01% |
51,828
+1,081
| +2% | +$121K |
|
|
INBX
2349
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $5.27M | ﹤0.01% |
158,085
+67,637
| +75% | +$2.06M |
|
2350
Energy Recovery
ERII
$397M
| $5.26M | ﹤0.01% |
276,228
-11,825
| -4% | -$240K |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.